SelenBio, Inc is a biotechnology company specializing in the prevention of bacterial biofilm formation for dental, healthcare, industrial, and consumer applications. Our proprietary SELDOXŽ antimicrobial technology is able to inhibit bacterial biofilm formation and attachment on surfaces through a covalently linked, catalytic, and safe compound that does not leach into the surrounding environment. These properties allow for effective, safe, and low cost protection against bacteria and biofilm for the duration of the useful life of the substrate. SelenBio partners with companies seeking to enhance their product effectiveness through antimicrobial protection and biofilm control. Source
No articles found.
NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...
NeuBase Therapeutics, Inc. is developing its mo...
TG Therapeutics is a biopharmaceutical company focused on the acquisition, develop...
TG Therapeutics is a biopharmaceutical company ...
The Healthereum Patient Behavior Management platform is a full cycle communication...
The Healthereum Patient Behavior Management pla...
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses o...
Aeolus Pharmaceuticals, Inc. is a biopharmaceut...
Join the National Investor Network and get the latest information with your interests in mind.